Global RNA Stabilization & Delivery Technology Advances Market Report 2021: LNP- and Bioconjugation-based Nonviral RNA Delivery Technologies to Gain Momentum in the Next 3 Years
February 15, 2022 05:43 ET
|
Research and Markets
Dublin, Feb. 15, 2022 (GLOBE NEWSWIRE) -- The "Technological Advances in RNA Stabilization & Delivery" report has been added to ResearchAndMarkets.com's offering. RNA therapeutics is a rapidly...
Global Viral and Non-Viral Vector Manufacturing Market 2022: Favorable Funding Scenario for Vector-Based Therapies | Rapid Uptake of Viral Vector to Develop Innovative Therapies
February 08, 2022 04:18 ET
|
Research and Markets
Dublin, Feb. 08, 2022 (GLOBE NEWSWIRE) -- The "Global Viral and Non-Viral Vector Manufacturing Market: Focus on Vector Type, Application, Disease and Region - Analysis and Forecast, 2021-2031"...
Global Viral Vectors for Cell Therapy Market Research Report 2022: Demographic Trends, New Developments, Cell and Gene Therapy Advancements, Company Performance Trends, M&As
January 19, 2022 06:38 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors Market for Cell Therapy Market: Analysis and Opportunities" report has been added to ResearchAndMarkets.com's offering. All market data...
Global Viral Vectors and Plasmid DNA 2021-2030 - Surge in Demand due to Increasing Number of COVID-19 Cases
January 19, 2022 04:48 ET
|
Research and Markets
Dublin, Jan. 19, 2022 (GLOBE NEWSWIRE) -- The "Viral Vectors and Plasmid DNA Global Market Report 2021: COVID-19 Implications and Growth to 2030" report has been added to ResearchAndMarkets.com's...
2021 Viral Vector Manufacturing for Cell and Gene Therapies Industry Report - Significant Venture Capital and Private Equity Funding Boost Innovations in Viral Vector Manufacturing
January 07, 2022 04:58 ET
|
Research and Markets
Dublin, Jan. 07, 2022 (GLOBE NEWSWIRE) -- The "Technology Developments in Viral Vector Manufacturing for Cell and Gene Therapies" report has been added to ResearchAndMarkets.com's offering. The...
Avid Bioservices Reports Financial Results for Second Quarter Ended October 31, 2021 and Recent Developments
December 07, 2021 16:05 ET
|
Avid Bioservices, Inc
-- Recorded Second Quarter Revenue of $26.1 Million -- -- Initiated Strategic Expansion into Viral Vector Development and Manufacturing Services for Cell and Gene Therapy -- -- Signed $36 Million in...
Global Cell & Gene Therapies Outsourcing Market Outlook Report 2021-2026
November 17, 2021 08:58 ET
|
Research and Markets
Dublin, Nov. 17, 2021 (GLOBE NEWSWIRE) -- The "Cell & Gene Therapies Market Outlook" report has been added to ResearchAndMarkets.com's offering. This report provides an overview of the current...
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
November 04, 2021 08:05 ET
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Global RNAi Technologies, Companies & Markets Report 2021-2028: 168 Companies with 231 Collaborations - 34 are Developing RNAi-based Therapeutics and 36 are Involved in microRNAs
November 04, 2021 06:58 ET
|
Research and Markets
Dublin, Nov. 04, 2021 (GLOBE NEWSWIRE) -- The "RNAi - Technologies, Markets & Companies" report from Jain PharmaBiotech has been added to ResearchAndMarkets.com's offering. The markets for...
Global Transfection Reagents and Equipment Market (2021 to 2026) - Growth, Trends, COVID-19 Impact and Forecasts
October 25, 2021 06:43 ET
|
Research and Markets
Dublin, Oct. 25, 2021 (GLOBE NEWSWIRE) -- The "Transfection Reagents and Equipment Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report has been added to...